Clinical trials at Emory and Piedmont are signaling a potential breakthrough in treating pancreatic cancer, one of the nation ...

The discovery of a drug called daraxonrasib, which a Florida doctor was part of, could have implications for extending ...

What does “GLP-1-friendly” actually mean?

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.

Hollywood’s most famous hospital has just swung open its doors in London - Hollywood’s hospital to the stars, from Frank ...

Bengaluru: Reliance Retail has appointed Sandeep Karwa, former Coupang Taiwan country head and ex-Flipkart Ads vice president, as the new CEO for Ajio, Shein and the company’s other online fashion and ...

Dennis Locorriere, founding member of the Seventies country rock band Dr. Hook and the Medicine Show, has died at the age of 76. Locorriere died Saturday following a “long and courageous battle with ...

In clinical trials, the drug was shown to almost double the survival time for pancreatic cancer patients. Here's how it works and who can get it.

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...

An experimental treatment has doubled one-year survival rates for pancreatic cancer, one of the deadliest types of cancer, a new study reports. The drug, called elraglusib, targets the protective web ...